For laboratory research use only. Not for human consumption. Not for clinical or therapeutic use. Not evaluated by the FDA.
For laboratory research use only. Not for human consumption. Not for clinical or therapeutic use. Not evaluated by the FDA.
Research Comparison
BPC-157 and TB-500 are the two most-studied recovery research peptides, with complementary mechanisms. BPC-157 is a gastric-derived pentadecapeptide studied for angiogenesis and cytoprotection, while TB-500 is a Thymosin Beta-4 fragment studied for actin regulation and cell migration. They are frequently combined.
| Attribute | BPC-157 | TB-500 |
|---|---|---|
| Origin | Gastric juice protein fragment | Thymosin Beta-4 fragment |
| Mechanism focus | Angiogenesis, cytoprotection | Actin upregulation, cell migration |
| Research area | Tendon, GI, neural | Soft tissue, cardiac, wound |
| Availability | Sold individually | Sold individually (also in the GLOW blend) |
They are frequently studied together because their mechanisms are complementary. Our GLOW research blend combines BPC-157 and TB-500 with GHK-Cu in a single vial.